<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>Chapter 4 Methods | Immunogenicity - Tiered Approach to Assess ADA Positive Samples</title>
  <meta name="description" content="This is a POC of using the tiered Approach to assess ADA positive samples for immunogenicity analysis" />
  <meta name="generator" content="bookdown 0.24 and GitBook 2.6.7" />

  <meta property="og:title" content="Chapter 4 Methods | Immunogenicity - Tiered Approach to Assess ADA Positive Samples" />
  <meta property="og:type" content="book" />
  
  
  <meta property="og:description" content="This is a POC of using the tiered Approach to assess ADA positive samples for immunogenicity analysis" />
  <meta name="github-repo" content="rstudio/bookdown-demo" />

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="Chapter 4 Methods | Immunogenicity - Tiered Approach to Assess ADA Positive Samples" />
  
  <meta name="twitter:description" content="This is a POC of using the tiered Approach to assess ADA positive samples for immunogenicity analysis" />
  

<meta name="author" content="Phil Bowsher" />


<meta name="date" content="2022-01-28" />

  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="literature.html"/>
<link rel="next" href="applications.html"/>
<script src="libs/header-attrs-2.11/header-attrs.js"></script>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.0.1/anchor-sections.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.0.1/anchor-sections.js"></script>
<script src="libs/htmlwidgets-1.5.4/htmlwidgets.js"></script>
<link href="libs/datatables-css-0.0.0/datatables-crosstalk.css" rel="stylesheet" />
<script src="libs/datatables-binding-0.19/datatables.js"></script>
<link href="libs/dt-core-1.10.20/css/jquery.dataTables.min.css" rel="stylesheet" />
<link href="libs/dt-core-1.10.20/css/jquery.dataTables.extra.css" rel="stylesheet" />
<script src="libs/dt-core-1.10.20/js/jquery.dataTables.min.js"></script>
<link href="libs/crosstalk-1.1.1/css/crosstalk.css" rel="stylesheet" />
<script src="libs/crosstalk-1.1.1/js/crosstalk.min.js"></script>
<script src="libs/plotly-binding-4.10.0/plotly.js"></script>
<script src="libs/typedarray-0.1/typedarray.min.js"></script>
<link href="libs/plotly-htmlwidgets-css-2.5.1/plotly-htmlwidgets.css" rel="stylesheet" />
<script src="libs/plotly-main-2.5.1/plotly-latest.min.js"></script>



<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">ANALYSIS AND INTERPRETATION OF A CLINICAL IMMUNOGENICITY DATA SET</a></li>

<li class="divider"></li>
<li class="chapter" data-level="1" data-path="index.html"><a href="index.html"><i class="fa fa-check"></i><b>1</b> Prerequisites</a></li>
<li class="chapter" data-level="2" data-path="intro.html"><a href="intro.html"><i class="fa fa-check"></i><b>2</b> Introduction</a>
<ul>
<li class="chapter" data-level="2.1" data-path="intro.html"><a href="intro.html#study-information"><i class="fa fa-check"></i><b>2.1</b> Study Information</a></li>
</ul></li>
<li class="chapter" data-level="3" data-path="literature.html"><a href="literature.html"><i class="fa fa-check"></i><b>3</b> Literature</a>
<ul>
<li class="chapter" data-level="3.1" data-path="literature.html"><a href="literature.html#case-study"><i class="fa fa-check"></i><b>3.1</b> Case Study</a></li>
<li class="chapter" data-level="3.2" data-path="literature.html"><a href="literature.html#statistical-analysis"><i class="fa fa-check"></i><b>3.2</b> Statistical Analysis</a></li>
</ul></li>
<li class="chapter" data-level="4" data-path="methods.html"><a href="methods.html"><i class="fa fa-check"></i><b>4</b> Methods</a>
<ul>
<li class="chapter" data-level="4.1" data-path="methods.html"><a href="methods.html#background"><i class="fa fa-check"></i><b>4.1</b> Background</a></li>
</ul></li>
<li class="chapter" data-level="5" data-path="applications.html"><a href="applications.html"><i class="fa fa-check"></i><b>5</b> Applications</a>
<ul>
<li class="chapter" data-level="5.0.1" data-path="applications.html"><a href="applications.html#ada-threetiered-testing-method"><i class="fa fa-check"></i><b>5.0.1</b> ADA Three‐tiered Testing Method</a></li>
<li class="chapter" data-level="5.1" data-path="applications.html"><a href="applications.html#example-one"><i class="fa fa-check"></i><b>5.1</b> Example one</a></li>
</ul></li>
<li class="chapter" data-level="6" data-path="final-words.html"><a href="final-words.html"><i class="fa fa-check"></i><b>6</b> Final Words</a>
<ul>
<li class="chapter" data-level="6.0.1" data-path="final-words.html"><a href="final-words.html#r-implementation"><i class="fa fa-check"></i><b>6.0.1</b> R implementation</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="references.html"><a href="references.html"><i class="fa fa-check"></i>References</a></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">Immunogenicity - Tiered Approach to Assess ADA Positive Samples</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="methods" class="section level1" number="4">
<h1><span class="header-section-number">Chapter 4</span> Methods</h1>
<div id="background" class="section level2" number="4.1">
<h2><span class="header-section-number">4.1</span> Background</h2>
<p>ADA Positive Sample: when ADA is detected in a sample, the sample is considered positive.</p>
<p>Therapeutic proteins (sometimes also called biologics, biopharmaceuticals, biological products, or biological medicinal products) and peptides have the potential to induce immunogenicity. The consequences of product immunogenicity vary from no evidience of clinical effect to severe, life-threatening responses.</p>
<p>Anti-drug antibodies (ADA) have been implicated in infusion reactions and anaphylaxis as well as immune complex-mediated disease. ADA have also caused secondary treatment failures (loss of efficacy) and, in rare occasions, more serious thrombocytopenia and pure red cell aplasia. Therefore, ADA are a medical concern in terms of safety and long-term efficacy of the drug and it is critical to evaluate their development in all patients during clinical studies, not just in a symptom-driven manner. With a goal of guiding medical practice, the elucidation of ADA responses and their characteristics relative to clinical consequences is vital <span class="citation">(<a href="#ref-shankar2014assessment" role="doc-biblioref">Shankar et al. 2014</a>)</span>.</p>
<p>ADA comprises neutralizing and non-neutralizing ADA. Other terms that have been used for ADA include anti-therapeutic antibody (ATA), anti-product antibody (APA), or anti-biologic antibody (ABA).</p>
<ul>
<li><p>Neutralizing ADA (NAb): ADA that inhibits or reduces the pharmacological activity of the biologic drug molecule, as determined by an <em>in vitro</em> test or animal-based bioassay method, regardless of its <em>in vitro</em> clinical relavence (i.e., whether or not test method results relate to clinical impact in the subject).</p></li>
<li><p>Non-neutralizing ADA (non-neutralizing antibody, non-
NAb): ADA that binds to the biologic drug molecule but
does not inhibit its pharmacological activity in an in vitro
test or animal-based bioassay method, regardless of its in
vivo clinical relevance (i.e., whether or not test method
results relate to clinical impact in the subject).</p></li>
</ul>
<p>ADA three‐tiered testing strategy is deployed here to assess ADA.</p>

</div>
</div>
<h3>References</h3>
<div id="refs" class="references csl-bib-body hanging-indent">
<div id="ref-shankar2014assessment" class="csl-entry">
Shankar, Gopi, S Arkin, L Cocea, V Devanarayan, S Kirshner, A Kromminga, V Quarmby, et al. 2014. <span>“Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides-Harmonized Terminology and Tactical Recommendations.”</span> <em>The AAPS Journal</em> 16 (4): 658–73.
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="literature.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="applications.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/rstudio/bookdown-demo/edit/master/03-method.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["bookdown-demo.pdf", "bookdown-demo.epub"],
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "subsection"
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
